Literature DB >> 10780783

Accuracy of family history of cancer: clinical genetic implications.

R H Sijmons1, A E Boonstra, J Reefhuis, J M Hordijk-Hos, H E de Walle, J C Oosterwijk, M C Cornel.   

Abstract

Family medical history is the cornerstone of clinical genetic diagnosis and management in cases of familial cancer. The soundness of medical decisions can be compromised if reports by the family on affected relatives are inaccurate. Although very time consuming, family medical histories are therefore routinely verified. To investigate whether such verification is clinically justified, we retrospectively analysed the accuracy of a consecutive series of 383 tumour reports from counsellees on 120 families in our clinic. We evaluated these families for the impact of verification on clinical genetic diagnosis and management. Accuracy according to cancer type showed marked variation, ranging from 93% and 89% for breast cancer and colorectal cancer, respectively, to 42% and 37% for extra-colorectal alimentary tract cancer and uterine cancer. Accuracy was related to the degree of kinship of the affected relative, but not to age and gender of the counsellee, nor to the reason for referral or personal history of cancer. Age at diagnosis and multiple primary tumours were reported accurately in 97% and 94% of cases, respectively. In six out of 120 families verification data changed clinical genetic management, in five of these the genetic risk was reduced. Although verification of all reported cancer cases in a family remains the 'gold standard' for clinical as well as research purposes, verification of reports on breast cancer can be limited without seriously compromising medical decision making. In cases where verification is impossible because medical records are unavailable, findings from studies such as ours may help in interpreting family histories.

Entities:  

Mesh:

Year:  2000        PMID: 10780783     DOI: 10.1038/sj.ejhg.5200441

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  30 in total

1.  Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.

Authors:  R C Niessen; M J W Berends; Y Wu; R H Sijmons; H Hollema; M J L Ligtenberg; H E K de Walle; E G E de Vries; A Karrenbeld; C H C M Buys; A G J van der Zee; R M W Hofstra; J H Kleibeuker
Journal:  Gut       Date:  2006-04-24       Impact factor: 23.059

2.  Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations.

Authors:  Marta M Reis; Dorothy Young; Lorna McLeish; David Goudie; Alan Cook; Frank Sullivan; Helen Vysny; Alison Fordyce; Roger Black; Manouche Tavakoli; Michael Steel
Journal:  Fam Cancer       Date:  2006-07-01       Impact factor: 2.375

Review 3.  Lynch syndrome: clinical, pathological, and genetic insights.

Authors:  Ralph Schneider; Claudia Schneider; Matthias Kloor; Alois Fürst; Gabriela Möslein
Journal:  Langenbecks Arch Surg       Date:  2012-02-24       Impact factor: 3.445

4.  Confirmation of family cancer history reported in a population-based survey.

Authors:  Phuong L Mai; Anne O Garceau; Barry I Graubard; Marsha Dunn; Timothy S McNeel; Lou Gonsalves; Mitchell H Gail; Mark H Greene; Gordon B Willis; Louise Wideroff
Journal:  J Natl Cancer Inst       Date:  2011-05-11       Impact factor: 13.506

5.  American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

Authors:  Karen H Lu; Marie E Wood; Molly Daniels; Cathy Burke; James Ford; Noah D Kauff; Wendy Kohlmann; Noralane M Lindor; Therese M Mulvey; Linda Robinson; Wendy S Rubinstein; Elena M Stoffel; Carrie Snyder; Sapna Syngal; Janette K Merrill; Dana Swartzberg Wollins; Kevin S Hughes
Journal:  J Clin Oncol       Date:  2014-02-03       Impact factor: 44.544

6.  Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial.

Authors:  L I Overbeek; R P Hermens; J H van Krieken; E M Adang; M Casparie; F M Nagengast; M J Ligtenberg; N Hoogerbrugge
Journal:  Virchows Arch       Date:  2010-04-09       Impact factor: 4.064

7.  Improving calculation, interpretation and communication of familial colorectal cancer risk: protocol for a randomized controlled trial.

Authors:  Nicky Dekker; Rosella P M G Hermens; Glyn Elwyn; Trudy van der Weijden; Fokko M Nagengast; Peter van Duijvendijk; Simone Salemink; Eddy Adang; J Han J M van Krieken; Marjolijn J L Ligtenberg; Nicoline Hoogerbrugge
Journal:  Implement Sci       Date:  2010-01-28       Impact factor: 7.327

8.  Familial cervical cancer: case reports, review and clinical implications.

Authors:  Margreet Zoodsma; Rolf H Sijmons; Elisabeth Ge de Vries; Ate Gj van der Zee
Journal:  Hered Cancer Clin Pract       Date:  2004-05-15       Impact factor: 2.857

9.  Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.

Authors:  Elena Stoffel; Bhramar Mukherjee; Victoria M Raymond; Nabihah Tayob; Fay Kastrinos; Jennifer Sparr; Fei Wang; Prathap Bandipalliam; Sapna Syngal; Stephen B Gruber
Journal:  Gastroenterology       Date:  2009-07-18       Impact factor: 22.682

10.  Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy.

Authors:  Fay Kastrinos; John I Allen; David H Stockwell; Elena M Stoffel; Earl F Cook; Muthoka L Mutinga; Judith Balmaña; Sapna Syngal
Journal:  Am J Gastroenterol       Date:  2009-04-28       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.